Company Email Format

OncoMyx Therapeutics

Pharmaceutical Manufacturing 24654 N Lake Pleasant Parkway 3 employees

Employees: 3
Contacts: 1
Emails: 1
Phones: 1

oncomyx.com LinkedIn Crunchbase

OncoMyx Therapeutics Overview

Headquarters: 24654 N Lake Pleasant Parkway
Phone Number: Available in AeroLeads
Website: oncomyx.com
Industry: Pharmaceutical Manufacturing
Employees: 3
Founded: 2018
Funding: 50.0M
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

oncolytic virus Oncology lung cancer multiple myeloma acute myeloid leukemia bladder cancer ovarian cancer drug development immunotherapy hematology medical oncology virology

About OncoMyx Therapeutics

OncoMyx Therapeutics targets hematologic and solid tumors with unique oncolytic virus called myxoma (MYXV) and a novel patented systemic delivery approach. The myxoma program is the result of two decades of oncolytic virus research in the laboratory of Professor Grant McFadden. Myxoma is a pox virus that is highly immunostimulatory, and is non-pathogenic in any organism outside of rabbits. The virus has a unique ability to be carried systemically by human leukocytes where it can then infect tumor cells. Programs are in development for both hematology (myeloma and AML) as well as solid tumors. Professor McFadden sequenced the myxoma virus genome in 1999, and since then has produced dozens of genetically engineered constructs, demonstrating its ability as an oncolytic agent across many tumors in preclinical cell and animal models.